Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Holly Ingraham
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Physiology
Anatomy
Sign-in to see full Profile
Network (preview)
8
Rosenfeld, Michael
7
Nachtigal, Mark
6
Krylova, Irina
6
Fletterick, Robert
5
Desclozeaux, Marion
4
Bland, Michelle
4
Roberts, Lori
4
Sablin, Elena
3
Tran, Phu
3
Parker, Keith
3
Simmons, Donna
3
Visser, Jenny
3
Kapiloff, Michael
3
Hammer, Gary
3
Akana, Susan
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Holly Ingraham (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lin Benjamin C; Suzawa Miyuki; Blind Raymond D; Tobias Sandra C; Bulun Serdar E; Scanlan Thomas S; Ingraham Holly A
Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.
Cancer research 2009;69(13):5415-23.
-
2009: Sablin Elena P; Blind Raymond D; Krylova Irina N; Ingraham Jared G; Cai Fang; Williams Jon D; Fletterick Robert J; Ingraham Holly A
Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands.
Molecular endocrinology (Baltimore, Md.) 2009;23(1):25-34.
-
2009: Kurrasch Deborah M; Nevin Linda M; Wong Jinny S; Baier Herwig; Ingraham Holly A
Neuroendocrine transcriptional programs adapt dynamically to the supply and demand for neuropeptides as revealed in NSF mutant zebrafish.
Neural development 2009;4():22.
-
2008: Campbell Lioudmila A; Faivre Emily J; Show Matthew D; Ingraham Jared G; Flinders Jeremy; Gross John D; Ingraham Holly A
Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1).
Molecular and cellular biology 2008;28(24):7476-86.
-
2008: Sablin Elena P; Woods April; Krylova Irina N; Hwang Peter; Ingraham Holly A; Fletterick Robert J
The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(47):18390-5.
-
2008: Suzawa Miyuki; Ingraham Holly A
The herbicide atrazine activates endocrine gene networks via non-steroidal NR5A nuclear receptors in fish and mammalian cells.
PloS one 2008;3(5):e2117.
-
2007: Kurrasch Deborah M; Cheung Clement C; Lee Florence Y; Tran Phu V; Hata Kenji; Ingraham Holly A
The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(50):13624-34.
-
2006: Tran Phu V; Akana Susan F; Malkovska Irena; Dallman Mary F; Parada Luis F; Ingraham Holly A
Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage.
The Journal of comparative neurology 2006;498(5):637-48.
-
2005: Ingraham Holly A; Redinbo Matthew R
Orphan nuclear receptors adopted by crystallography.
Current opinion in structural biology 2005;15(6):708-15.
-
2005: Lee Martin B; Lebedeva Lioudmila A; Suzawa Miyuki; Wadekar Subhagya A; Desclozeaux Marion; Ingraham Holly A
The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Molecular and cellular biology 2005;25(5):1879-90.
-
2005: Krylova Irina N; Sablin Elena P; Moore Jamie; Xu Robert X; Waitt Gregory M; MacKay J Andrew; Juzumiene Dalia; Bynum Jane M; Madauss Kevin; Montana Valerie; Lebedeva Lioudmila; Suzawa Miyuki; Williams Jon D; Williams Shawn P; Guy Rodney K; Thornton Joseph W; Fletterick Robert J; Willson Timothy M; Ingraham Holly A
Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1.
Cell 2005;120(3):343-55.
-
2004: Bland Michelle L; Fowkes Robert C; Ingraham Holly A
Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function.
Molecular endocrinology (Baltimore, Md.) 2004;18(4):941-52.
-
2003: Fowkes Robert C; Desclozeaux Marion; Patel Mayur V; Aylwin Simon J B; King Peter; Ingraham Holly A; Burrin Jacky M
Steroidogenic factor-1 and the gonadotrope-specific element enhance basal and pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein hormone alpha-subunit gene in gonadotropes.
Molecular endocrinology (Baltimore, Md.) 2003;17(11):2177-88.
-
2003: Jordan Brian K; Shen Jennifer H-C; Olaso Robert; Ingraham Holly A; Vilain Eric
Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):10866-71.
-
2003: Sablin Elena P; Krylova Irina N; Fletterick Robert J; Ingraham Holly A
Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1.
Molecular cell 2003;11(6):1575-85.
-
2003: Bland Michelle L; Desclozeaux Marion; Ingraham Holly A
Tissue growth and remodeling of the embryonic and adult adrenal gland.
Annals of the New York Academy of Sciences 2003;995():59-72.
-
2003: Tran Phu V; Lee Martin B; Marín Oscar; Xu Baoji; Jones Kevin R; Reichardt Louis F; Rubenstein John R; Ingraham Holly A
Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons.
Molecular and cellular neurosciences 2003;22(4):441-53.
-
2003: Huber B Russell; Desclozeaux Marion; West Brian L; Cunha-Lima Suzana T; Nguyen Hoa T; Baxter John D; Ingraham Holly A; Fletterick Robert J
Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain.
Molecular endocrinology (Baltimore, Md.) 2003;17(1):107-16.
-
2002: Desclozeaux Marion; Krylova Irina N; Horn Florence; Fletterick Robert J; Ingraham Holly A
Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1.
Molecular and cellular biology 2002;22(20):7193-203.
-
2002: Roberts Lori M; Visser Jenny A; Ingraham Holly A
Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
Development (Cambridge, England) 2002;129(6):1487-96.
-
2002: Shen Jennifer H-C; Ingraham Holly A
Regulation of the orphan nuclear receptor steroidogenic factor 1 by Sox proteins.
Molecular endocrinology (Baltimore, Md.) 2002;16(3):529-40.
-
2002: Durlinger Alexandra L L; Gruijters Maria J G; Kramer Piet; Karels Bas; Ingraham Holly A; Nachtigal Mark W; Uilenbroek Jan Th J; Grootegoed J Anton; Themmen Axel P N
Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.
Endocrinology 2002;143(3):1076-84.
-
2001: Visser J A; Olaso R; Verhoef-Post M; Kramer P; Themmen A P; Ingraham H A
The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Molecular endocrinology (Baltimore, Md.) 2001;15(6):936-45.
-
2001: McGee E A; Smith R; Spears N; Nachtigal M W; Ingraham H; Hsueh A J
Müllerian inhibitory substance induces growth of rat preantral ovarian follicles.
Biology of reproduction 2001;64(1):293-8.
-
2000: Bland M L; Jamieson C A; Akana S F; Bornstein S R; Eisenhofer G; Dallman M F; Ingraham H A
Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(26):14488-93.
-
2000: Bland M L; Jamieson C; Akana S; Dallman M; Ingraham H A
Gene dosage effects of steroidogenic factor 1 (SF-1) in adrenal development and the stress.
Endocrine research 2000;26(4):515-6.
-
2000: Ingraham H A; Hirokawa Y; Roberts L M; Mellon S H; McGee E; Nachtigal M W; Visser J A
Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Recent progress in hormone research 2000;55():53-67; discussion 67-8.
-
1999: Roberts L M; Shen J; Ingraham H A
New solutions to an ancient riddle: defining the differences between Adam and Eve.
American journal of human genetics 1999;65(4):933-42.
-
1999: Hammer G D; Ingraham H A
Steroidogenic factor-1: its role in endocrine organ development and differentiation.
Frontiers in neuroendocrinology 1999;20(3):199-223.
-
1999: Hammer G D; Krylova I; Zhang Y; Darimont B D; Simpson K; Weigel N L; Ingraham H A
Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress.
Molecular cell 1999;3(4):521-6.
-
1999: Roberts L M; Hirokawa Y; Nachtigal M W; Ingraham H A
Paracrine-mediated apoptosis in reproductive tract development.
Developmental biology 1999;208(1):110-22.
-
1998: Bedford F K; Julius D; Ingraham H A
Neuronal expression of the 5HT3 serotonin receptor gene requires nuclear factor 1 complexes.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(16):6186-94.
-
1998: Nachtigal M W; Hirokawa Y; Enyeart-VanHouten D L; Flanagan J N; Hammer G D; Ingraham H A
Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
Cell 1998;93(3):445-54.
-
1997: Giuili G; Shen W H; Ingraham H A
The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo.
Development (Cambridge, England) 1997;124(9):1799-807.
-
1996: Nachtigal M W; Ingraham H A
Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(15):7711-6.
-
1996: Bedford F K; Christopherson K; Nachtigal M W; Shen W H; Julius D J; Ingraham H A
Molecular biology of pituitary development and disease.
Hormone research 1996;45 Suppl 1():19-21.
-
1994: Ingraham H A; Lala D S; Ikeda Y; Luo X; Shen W H; Nachtigal M W; Abbud R; Nilson J H; Parker K L
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis.
Genes & development 1994;8(19):2302-12.
-
1994: Shen W H; Moore C C; Ikeda Y; Parker K L; Ingraham H A
Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade.
Cell 1994;77(5):651-61.
-
1994: Ikeda Y; Shen W H; Ingraham H A; Parker K L
Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases.
Molecular endocrinology (Baltimore, Md.) 1994;8(5):654-62.
-
1991: Carpenter C D; Ingraham H A; Cochet C; Walton G M; Lazar C S; Sowadski J M; Rosenfeld M G; Gill G N
Structural analysis of the transmembrane domain of the epidermal growth factor receptor.
The Journal of biological chemistry 1991;266(9):5750-5.
-
1990: Chen R P; Ingraham H A; Treacy M N; Albert V R; Wilson L; Rosenfeld M G
Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements.
Nature 1990;346(6284):583-6.
-
1990: Heisermann G J; Wiley H S; Walsh B J; Ingraham H A; Fiol C J; Gill G N
Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor.
The Journal of biological chemistry 1990;265(22):12820-7.
-
1990: Ingraham H A; Flynn S E; Voss J W; Albert V R; Kapiloff M S; Wilson L; Rosenfeld M G
The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions.
Cell 1990;61(6):1021-33.
-
1990: Simmons D M; Voss J W; Ingraham H A; Holloway J M; Broide R S; Rosenfeld M G; Swanson L W
Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors.
Genes & development 1990;4(5):695-711.
-
1990: Ingraham H A; Albert V R; Chen R P; Crenshaw 3d E B; Elsholtz H P; He X; Kapiloff M S; Mangalam H J; Swanson L W; Treacy M N
A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development.
Annual review of physiology 1990;52():773-91.
-
1989: He X; Treacy M N; Simmons D M; Ingraham H A; Swanson L W; Rosenfeld M G
Expression of a large family of POU-domain regulatory genes in mammalian brain development.
Nature 1989;340(6228):35-41.
-
1989: Mangalam H J; Albert V R; Ingraham H A; Kapiloff M; Wilson L; Nelson C; Elsholtz H; Rosenfeld M G
A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally.
Genes & development 1989;3(7):946-58.
-
1988: Ingraham H A; Chen R P; Mangalam H J; Elsholtz H P; Flynn S E; Lin C R; Simmons D M; Swanson L; Rosenfeld M G
A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype.
Cell 1988;55(3):519-29.
-
1988: Gill G N; Chen W S; Lazar C S; Glenney J R; Wiley H S; Ingraham H A; Rosenfeld M G
Role of intrinsic protein tyrosine kinase in function and metabolism of the epidermal growth factor receptor.
Cold Spring Harbor symposia on quantitative biology 1988;53 Pt 1():467-76.
Sign-in to see more